AbbVie Inc. (ABBV) vs Oracle Corporation (ORCL)
A side-by-side comparison of AbbVie Inc. and Oracle Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
Different business models: ABBV is classified in Healthcare; ORCL is classified in Technology. Margin, capital intensity, and valuation differences should be interpreted in that sector context.
ABBV
AbbVie Inc.
$263.48HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
ORCL
Oracle Corporation
$119.99TechnologyDelayed quote: Jul 28, 2026, 3:59 PM EDT
Total return — ABBV vs ORCL
growth of $100 · dividends reinvested · last 14yABBV +1164.7%ORCL +353.1%ABBV compounded faster
ABBV ORCL
ABBV vs ORCL: by the numbers
- •ABBV is the larger company ($465.51B vs $345.63B market cap).
- •ORCL trades at the lower trailing earnings multiple (20.57 vs 125.98 P/E), one valuation lens rather than an overall verdict.
- •ORCL converts more revenue to profit (25.37% vs 5.79% net margin).
- •ORCL grew revenue faster over the past five years (10.72% vs 4.59% CAGR).
- •ABBV pays the higher dividend yield (2.62% vs 1.67%).
Metrics side by side
Valuation
| Metric | ABBV | ORCL |
|---|---|---|
| P/E ratio | 125.98 | 20.57 |
| Forward P/E | N/A | 16.01 |
| P/S ratio | 7.26 | 5.19 |
| P/B ratio | 16.57 | 8.22 |
| PEG ratio | N/A | 1.26 |
| EV / EBITDA | 20.46 | 16.52 |
| FCF yield | 4.58% | N/A |
Profitability
| Metric | ABBV | ORCL |
|---|---|---|
| Gross margin | 70.68% | 65.81% |
| Operating margin | 27.60% | 30.85% |
| Net margin | 5.79% | 25.37% |
| ROE | 13.23% | 40.20% |
| ROIC | 12.97% | 7.99% |
Dividends
| Metric | ABBV | ORCL |
|---|---|---|
| Dividend yield | 2.62% | 1.67% |
| Payout ratio | 284.39% | 33.67% |
Growth (annualized)
| Metric | ABBV | ORCL |
|---|---|---|
| Revenue CAGR (5Y) | 4.59% | 10.72% |
| EPS CAGR (5Y) | -2.79% | 4.93% |
| FCF CAGR (5Y) | 3.24% | -13.18% |
| Total return CAGR (5Y) | 21.24% | 7.88% |
Frequently asked
- Which has the lower trailing P/E, ABBV or ORCL?
- ORCL has the lower trailing P/E: ABBV trades at 125.98 and ORCL at 20.57. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, ABBV or ORCL?
- Over the past five years, ORCL grew revenue faster — ABBV at a 4.59% CAGR versus ORCL at 10.72%.
- Does ABBV or ORCL pay a bigger dividend?
- ABBV yields 2.62% and ORCL yields 1.67% based on trailing dividends and the latest price.
- Is ABBV or ORCL more profitable?
- ORCL runs the higher net margin — ABBV at 5.79% versus ORCL at 25.37%.
- How have ABBV and ORCL total returns compared?
- Over the past 10 years, ABBV delivered 19.57% and ORCL delivered 13.02% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AbbVie P/E ratioOracle P/E ratioAbbVie dividend yieldOracle dividend yieldAbbVie ROEOracle ROEAbbVie operating marginOracle operating marginAbbVie revenue growthOracle revenue growthAbbVie free cash flowOracle free cash flow
AbbVie & Oracle appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.